Recent Successes and Noteworthy Future Prospects in the Treatment of Chronic Hepatitis C
出版年份 2012 全文链接
标题
Recent Successes and Noteworthy Future Prospects in the Treatment of Chronic Hepatitis C
作者
关键词
-
出版物
CLINICAL INFECTIOUS DISEASES
Volume 55, Issue suppl_1, Pages S16-S24
出版商
Oxford University Press (OUP)
发表日期
2012-06-20
DOI
10.1093/cid/cis391
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b
- (2013) Donald M. Jensen ANNALS OF INTERNAL MEDICINE
- 13 A 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R, ABT-072, AND RIBAVIRIN WAS WELL TOLERATED AND ACHIEVED SUSTAINED VIROLOGIC RESPONSE IN 91% TREATMENT-NAIVE HCV IL28B-CC GENOTYPE-1-INFECTED SUBJECTS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2
- (2012) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 1206 ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN HCV GENOTYPE 1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS
- (2012) F. Poordad et al. JOURNAL OF HEPATOLOGY
- 1415 CONFIRMATION THAT QUADRUPLE THERAPY WITH DACLATASVIR (NS5A INHIBITOR), ASUNAPREVIR (NS3 INHIBITOR) AND PEGINTERFERON/RIBAVIRIN RESULTS IN HIGH RATE OF SVR4 IN HCV GENOTYPE 1 NULL RESPONDERS
- (2012) A. Lok et al. JOURNAL OF HEPATOLOGY
- 1412 INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS
- (2012) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- 1113 ELECTRON: ONCE DAILY PSI-7977 PLUS RBV IN HCV GT1/2/3
- (2012) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
- (2011) Lisa I. Backus et al. Clinical Gastroenterology and Hepatology
- The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C
- (2011) Stefan Zeuzem et al. HEPATOLOGY
- Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir
- (2011) Simone Susser et al. JOURNAL OF CLINICAL VIROLOGY
- 425 FOUR-WEEK TREATMENT WITH GS-9256 AND TEGOBUVIR (GS-9190), ± RBV ± PEG, RESULTS IN ENHANCED VIRAL SUPPRESSION ON FOLLOW-UP PEG/RBV THERAPY, IN GENOTYPI 1A/1B HCV PATIENTS
- (2011) G.R. Foster et al. JOURNAL OF HEPATOLOGY
- 1154 PREVALENCE OF ANTI-HCV AND HCV-RNA AMONG HEALTH CARE WORKERS AND PATIENTS OF MULTISPECIALISTIC HOSPITALS IN POLAND
- (2011) R. Flisiak et al. JOURNAL OF HEPATOLOGY
- 1376 THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT
- (2011) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 1356 QUADRUPLE THERAPY WITH BMS-790052, BMS-650032 AND PEG-IFN/RBV FOR 24 WEEKS RESULTS IN 100% SVR12 IN HCV GENOTYPE 1 NULL RESPONDERS
- (2011) A. Lok et al. JOURNAL OF HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Hepatitis C Infection
- (2011) Hugo R. Rosen NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- Outcome of sustained virological responders with histologically advanced chronic hepatitis C
- (2010) Timothy R. Morgan et al. HEPATOLOGY
- Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
- (2010) Paul Y Kwo et al. LANCET
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now